Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-31
1989-10-03
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544279, A61K 31505, C07D47100
Patent
active
048717460
ABSTRACT:
N-[N-(Tetrahydropyrido[2,3-d]pyrimidinylmethyl) aminomethylbenzoyl]glutamic acid derivatives are antineoplastic agents with an effect on one or more enzymes which utilize metabolic derivatives of folic acid. The compounds can be prepared by allowing a protected aminomethylbenzoylglutamic acid derivative to react with 2-amino-4-hydroxy-6-formylpyrido[2,3-d]pyrimidine, reducing the intermediate Schiff base, and subjecting the intermediate to catalytic hydrogenation. A typical embodiment is (S,S) N-[N-(2-amino-4-hydroxy-5,6,7,8- tetrahydropyrido-[2,3-d]pyrimidin-6-ylmethyl)-4-aminomethylbenzoyl]-glutam ic acid.
REFERENCES:
patent: 4596805 (1986-06-01), Jiang
Cutting, "Handbook of Pharmacology", Prentice-Hall, Norwalk, Connecticut, (1984), pp. 119-140.
Hamby James M.
Shih Chuan
Taylor Edward C.
Eli Lilly and Company
Lee Mary C.
The Trustees of Princeton University
Whittenbaugh Robert C.
LandOfFree
N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664561